1-159206153-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_Very_StrongBP7BS2_Supporting
The NM_002036.4(ACKR1):c.714G>A(p.Gly238Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00562 in 1,614,250 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0049 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0057 ( 36 hom. )
Consequence
ACKR1
NM_002036.4 synonymous
NM_002036.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.687
Genes affected
ACKR1 (HGNC:4035): (atypical chemokine receptor 1 (Duffy blood group)) The protein encoded by this gene is a glycosylated membrane protein and a non-specific receptor for several chemokines. The encoded protein is the receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi. Polymorphisms in this gene are the basis of the Duffy blood group system. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-159206153-G-A is Benign according to our data. Variant chr1-159206153-G-A is described in ClinVar as [Benign]. Clinvar id is 777331.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.687 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 BG geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACKR1 | ENST00000368122.4 | c.714G>A | p.Gly238Gly | synonymous_variant | 2/2 | 1 | NM_002036.4 | ENSP00000357104.1 | ||
ACKR1 | ENST00000368121.6 | c.720G>A | p.Gly240Gly | synonymous_variant | 2/2 | 6 | ENSP00000357103.2 | |||
ACKR1 | ENST00000435307.2 | n.895G>A | non_coding_transcript_exon_variant | 1/1 | 3 | |||||
CADM3-AS1 | ENST00000609696.1 | n.164+1657C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00485 AC: 739AN: 152246Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
739
AN:
152246
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00535 AC: 1345AN: 251472Hom.: 8 AF XY: 0.00540 AC XY: 734AN XY: 135910
GnomAD3 exomes
AF:
AC:
1345
AN:
251472
Hom.:
AF XY:
AC XY:
734
AN XY:
135910
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00570 AC: 8329AN: 1461886Hom.: 36 Cov.: 34 AF XY: 0.00577 AC XY: 4193AN XY: 727248
GnomAD4 exome
AF:
AC:
8329
AN:
1461886
Hom.:
Cov.:
34
AF XY:
AC XY:
4193
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00486 AC: 740AN: 152364Hom.: 3 Cov.: 33 AF XY: 0.00466 AC XY: 347AN XY: 74508
GnomAD4 genome
AF:
AC:
740
AN:
152364
Hom.:
Cov.:
33
AF XY:
AC XY:
347
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 31, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at